Articles related to DIGITAL HEALTH

Nuvo’s INVU™ platform provides FDA-cleared, physician-prescribed remote fetal non-stress tests, improving accessibility and reducing healthcare staff burden with real-time maternal and fetal health data.

Nearly 50% of people struggle with medication adherence. Mobile apps offering customizable reminders and interaction warnings can significantly support patients in managing their medication schedules effectively.

The FDA-approved Rejoyn app, designed for major depressive disorder, combines therapeutic exercises and emotional regulation training to complement antidepressant therapy, showing significant improvement in clinical trials.

HHS is offering a new funding opportunity to advance AI in healthcare and improve health IT in behavioral health settings. The initiative focuses on developing scalable methods to enhance EHR data quality for AI tools and accelerating health IT capabilities in behavioral health.

AI is enhancing surgical care through advanced preoperative planning, intraoperative decision-making, and postoperative monitoring, promising improved patient outcomes and operational efficiency.

Rejoyn represents a significant advancement in the treatment of major depressive disorder, requiring prescription use and integrating brain-training exercises developed by leading mental health experts.